Pune, India, December, 2022 /MRFR Press Release/- Market Research Future published a half-cooked research report on the Global Hemorrhoids Treatment Market.
The Global Hemorrhoids Treatment Market is expected to grow at an approximate CAGR of 5.50% during forecast period, 2022–2030 and is projected to hit USD 725.9 Million by 2030. Factors such as growing demand for treatment; increasing prevalence of lifestyle diseases, increase in number of surgeries which may require these treatments for postoperative care; and increase in demand to reduce complications & infections relating to hemorrhoids are expected to drive the market. Growing aging population contributes to increased need of hemorrhoids treatment.
The Global Hemorrhoids Treatment Market is segmented based on treatment type, route of administration, distribution channel, and region.On the basis of treatment type, the market is segmented into drugs (further sub segmented into laxatives, NSAIDs, and herbals) non-surgical procedures (further sub segmented into band litigation, sclerotherapy, cryotherapy) surgical procedures. Further, on the basis of route of administration the market is segmented into oral, topical agents. Distribution channel is segmented into retail pharmacies, hospital pharmacies, online pharmacies and others.
The Global Hemorrhoids Treatment Market is segmented on the basis of regions: Americas, Europe, Asia Pacific, and the Middle East & Africa. The Americas accounted for the major share of the market owing to the huge patient population, well-developed technology, and high healthcare expenditure. Asia Pacific accounted for the second largest market, which is followed by Europe. Asia Pacific is the fastest growing hemorrhoids treatment market owing to rapidly changing healthcare sector, huge patient pool in this region, and the presence of vast opportunities for the development of this market. Increasing government support for research & development, well-developed healthcare infrastructure, and presence of geriatric population have driven the European hemorrhoids treatment market. However, the Middle East & Africa has the least share in the market owing to the presence of poor and slow developing countries, especially, in African region. The Middle East held the major share of the regional market due to well-developed infrastructure and high spending.
Explore In-depth Details: Hemorrhoids Treatment Market Research Report
Some of the key players in the Global Hemorrhoids Treatment Market are Abbott Laboratories, AstraZeneca plc, Bayer AG, Boehringer Ingelheim GmbH, Boston Scientific Corporation, CONMED Corporation, Cook Medical, GlaxoSmithKline, Olympus Corporation, Pfizer Inc., Takeda Pharmaceutical Company, Taro pharmaceuticals Inc., Teva Pharmaceutical Industries Ltd, Astra Zeneca, Glenmark Pharmaceuticals and others
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
+1 646 845 9312